NASDAQ:INOV - Inovalon Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$10.25 +0.15 (+1.49 %)
(As of 05/24/2018 02:08 AM ET)
Previous Close$10.25
Today's Range$10.05 - $10.45
52-Week Range$8.90 - $17.80
Volume393,532 shs
Average Volume611,754 shs
Market Capitalization$1.54 billion
P/E Ratio44.57
Dividend YieldN/A
Beta1.02

About Inovalon (NASDAQ:INOV)

Inovalon logoInovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance. It serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. The company provides technology that supports approximately 500 healthcare organizations. Its platforms are informed by data pertaining to approximately 932,000 physicians; 455,000 clinical facilities; and approximately 240 million individuals and 37 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.

Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:INOV
CUSIPN/A
Phone301-809-4000

Debt

Debt-to-Equity Ratio0.31
Current Ratio4.48
Quick Ratio4.48

Price-To-Earnings

Trailing P/E Ratio44.57
Forward P/E Ratio53.95
P/E Growth3.72

Sales & Book Value

Annual Sales$449.36 million
Price / Sales3.47
Cash Flow$0.6094 per share
Price / Cash16.82
Book Value$4.15 per share
Price / Book2.47

Profitability

EPS (Most Recent Fiscal Year)$0.23
Net Income$34.81 million
Net Margins3.20%
Return on Equity2.50%
Return on Assets1.62%

Miscellaneous

Employees2,480
Outstanding Shares152,270,000

Inovalon (NASDAQ:INOV) Frequently Asked Questions

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

How were Inovalon's earnings last quarter?

Inovalon (NASDAQ:INOV) posted its quarterly earnings data on Tuesday, May, 8th. The technology company reported ($0.04) EPS for the quarter, missing the Zacks' consensus estimate of $0.06 by $0.10. The technology company had revenue of $92.76 million for the quarter, compared to analyst estimates of $107.76 million. Inovalon had a return on equity of 2.50% and a net margin of 3.20%. The company's quarterly revenue was down 14.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.07 earnings per share. View Inovalon's Earnings History.

What guidance has Inovalon issued on next quarter's earnings?

Inovalon issued an update on its FY18 earnings guidance on Tuesday, May, 8th. The company provided earnings per share (EPS) guidance of $0.32-0.38 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.39. The company issued revenue guidance of $568-593 million, compared to the consensus revenue estimate of $576.37 million.

What price target have analysts set for INOV?

4 equities research analysts have issued 12 month price objectives for Inovalon's stock. Their forecasts range from $10.00 to $14.00. On average, they expect Inovalon's share price to reach $12.00 in the next year. View Analyst Ratings for Inovalon.

Who are some of Inovalon's key competitors?

Who are Inovalon's key executives?

Inovalon's management team includes the folowing people:
  • Dr. Keith R. Dunleavy M.D., Chairman and Chief Exec. Officer (Age 49)
  • Mr. Robert A. Wychulis, Pres (Age 63)
  • Ms. Shauna L. Vernal, Former Chief Legal Officer & Corp. Sec. (Age 49)
  • Mr. Jonathan R. Boldt, Interim Chief Financial Officer
  • Ms. June D. Duchesne, Chief Legal Officer & Corp. Sec.

When did Inovalon IPO?

(INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Has Inovalon been receiving favorable news coverage?

News coverage about INOV stock has been trending somewhat positive this week, Accern reports. The research group identifies positive and negative media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Inovalon earned a media sentiment score of 0.21 on Accern's scale. They also gave news coverage about the technology company an impact score of 45.57 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are Inovalon's major shareholders?

Inovalon's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (2.92%), Neuberger Berman Group LLC (2.29%), Tikvah Management LLC (1.36%), Senvest Management LLC (0.88%), Northern Trust Corp (0.59%) and Prescott Group Capital Management L.L.C. (0.44%). Company insiders that own Inovalon stock include Daniel L Rizzo, Joseph R Rostock, Keith R Dunleavy, Robert A Wychulis, Shauna L Vernal, Thomas R Kloster, William D Green and William J Teuber Jr. View Institutional Ownership Trends for Inovalon.

Which major investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., Prescott Group Capital Management L.L.C., GSA Capital Partners LLP, Envestnet Asset Management Inc., Northern Trust Corp, Oppenheimer Asset Management Inc., California Public Employees Retirement System and Royal Bank of Canada. Company insiders that have sold Inovalon company stock in the last year include Robert A Wychulis and Shauna L Vernal. View Insider Buying and Selling for Inovalon.

Which major investors are buying Inovalon stock?

INOV stock was acquired by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Tikvah Management LLC, Millennium Management LLC, Algert Global LLC, Senvest Management LLC, Trexquant Investment LP, Barclays PLC and Cowen Prime Services LLC. Company insiders that have bought Inovalon stock in the last two years include Keith R Dunleavy, Robert A Wychulis, William D Green and William J Teuber Jr. View Insider Buying and Selling for Inovalon.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $10.25.

How big of a company is Inovalon?

Inovalon has a market capitalization of $1.54 billion and generates $449.36 million in revenue each year. The technology company earns $34.81 million in net income (profit) each year or $0.23 on an earnings per share basis. Inovalon employs 2,480 workers across the globe.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]


MarketBeat Community Rating for Inovalon (INOV)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  147 (Vote Outperform)
Underperform Votes:  215 (Vote Underperform)
Total Votes:  362
MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote "Outperform" if you believe INOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Inovalon (NASDAQ:INOV) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Inovalon in the last 12 months. Their average twelve-month price target is $12.00, suggesting that the stock has a possible upside of 17.07%. The high price target for INOV is $14.00 and the low price target for INOV is $10.00. There are currently 1 sell rating and 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.751.752.002.00
Ratings Breakdown: 1 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $12.00$12.00$13.3333$14.00
Price Target Upside: 17.07% upside0.84% upside4.99% upside18.13% downside

Inovalon (NASDAQ:INOV) Consensus Price Target History

Price Target History for Inovalon (NASDAQ:INOV)

Inovalon (NASDAQ:INOV) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/14/2018Morgan StanleyDowngradeEqual Weight ➝ Underweight$10.00HighView Rating Details
2/21/2018Wells Fargo & CoReiterated RatingMarket Perform ➝ Market Perform$16.00 ➝ $14.00HighView Rating Details
9/12/2017KeyCorpReiterated RatingHoldHighView Rating Details
6/16/2017Robert W. BairdReiterated RatingNeutral$11.00 ➝ $12.00LowView Rating Details
2/23/2017William BlairReiterated RatingMarket PerformN/AView Rating Details
2/13/2017Bank of AmericaDowngradeNeutral ➝ Underperform$10.00N/AView Rating Details
12/4/2016Pacific CrestSet Price TargetBuy$20.00N/AView Rating Details
10/24/2016First AnalysisInitiated CoverageEqual ➝ Equal Weight$14.00N/AView Rating Details
8/4/2016CitigroupLower Price TargetNeutral$18.00 ➝ $17.00N/AView Rating Details
8/4/2016Goldman Sachs GroupDowngradeBuy ➝ Neutral$25.00 ➝ $17.00N/AView Rating Details
8/4/2016Piper Jaffray CompaniesDowngradeNeutral ➝ Underweight$14.00 ➝ $11.00N/AView Rating Details
(Data available from 5/24/2016 forward)

Earnings

Inovalon (NASDAQ:INOV) Earnings History and Estimates Chart

Earnings by Quarter for Inovalon (NASDAQ:INOV)

Inovalon (NASDAQ:INOV) Earnings Estimates

2018 EPS Consensus Estimate: $0.32
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.04$0.04$0.04
Q2 20184$0.05$0.10$0.07
Q3 20183$0.10$0.12$0.11
Q4 20183$0.07$0.14$0.11

Inovalon (NASDAQ INOV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018Q1 2018$0.06($0.04)$107.76 million$92.76 millionViewN/AView Earnings Details
2/20/2018Q4 2017$0.07$0.06$116.83 million$114.60 millionViewListenView Earnings Details
11/1/2017Q3 2017$0.0840$0.09$114.79 million$115.90 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.07$0.08$108.73 million$110.60 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.05$0.05$102.05 million$108.31 millionViewListenView Earnings Details
2/22/2017Q4 2016$0.0290$0.05$95.10 million$96.09 millionViewListenView Earnings Details
11/2/2016Q316$0.06$0.10$102.38 million$105.01 millionViewListenView Earnings Details
8/3/2016Q2$0.14$0.14$126.86 million$123.80 millionViewListenView Earnings Details
5/4/2016Q116$0.08$0.05$97.96 million$102.70 millionViewN/AView Earnings Details
2/25/2016Q4$0.13$0.13$125.40 million$120.60 millionViewListenView Earnings Details
11/4/2015Q315$0.09$0.09$102.76 million$105.46 millionViewN/AView Earnings Details
8/5/2015Q215$0.18$0.17$122.06 million$117.62 millionViewListenView Earnings Details
5/6/2015Q115$0.09$0.11$91.00 million$93.60 millionViewListenView Earnings Details
3/25/2015Q414$0.11$0.11$89.20 million$89.90 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Inovalon (NASDAQ:INOV) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Inovalon (NASDAQ INOV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 50.93%
Institutional Ownership Percentage: 29.53%
Insider Trading History for Inovalon (NASDAQ:INOV)
Institutional Ownership by Quarter for Inovalon (NASDAQ:INOV)

Inovalon (NASDAQ INOV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2018Keith R DunleavyCEOBuy118,000$9.91$1,169,380.00318,753View SEC Filing  
5/14/2018Keith R DunleavyCEOBuy36,753$9.97$366,427.41318,753View SEC Filing  
1/23/2018Shauna L. VernalInsiderSell44,270$14.00$619,780.00View SEC Filing  
12/5/2017Robert A WychulisPresidentSell85,828$15.54$1,333,767.12466,286View SEC Filing  
11/17/2017Shauna L VernalInsiderSell5,908$16.01$94,587.0847,309View SEC Filing  
9/13/2017Keith R DunleavyCEOBuy62,000$16.38$1,015,560.00270,000View SEC Filing  
5/24/2017Shauna L VernalInsiderSell19,332$13.60$262,915.2066,261View SEC Filing  
5/8/2017Joseph R RostockInsiderSell104,649$13.07$1,367,762.43171,824View SEC Filing  
5/5/2017Keith R DunleavyCEOBuy40,000$12.98$519,200.00220,000View SEC Filing  
12/16/2016Robert A WychulisPresidentBuy1,675$9.29$15,560.7532,942View SEC Filing  
12/16/2016William D GreenDirectorBuy30,000$9.29$278,700.0068,351View SEC Filing  
12/14/2016Keith R DunleavyCEOBuy100,000$9.21$921,000.00180,000View SEC Filing  
11/11/2016Thomas R KlosterCFOSell109,899$15.53$1,706,731.4710,050View SEC Filing  
9/16/2016William D GreenDirectorBuy30,000$16.22$486,600.0038,351View SEC Filing  
9/8/2016William J Teuber JrDirectorBuy60,000$16.46$987,600.0069,559View SEC Filing  
7/12/2016Daniel L RizzoInsiderSell43,577$20.02$872,411.54320,385View SEC Filing  
5/9/2016Keith R DunleavyCEOBuy30,000$16.68$500,400.0053,147View SEC Filing  
3/4/2016Robert A WychulisPresidentSell33,003$18.17$599,664.5163,666View SEC Filing  
12/9/2015Daniel L RizzoInsiderSell24,000$20.00$480,000.00340,000View SEC Filing  
12/4/2015Shauna L. VernalinsiderSell33,437$18.55$620,256.3535,642View SEC Filing  
8/28/2015Christopher E. GreinerCOOSell124,813$21.20$2,646,035.60View SEC Filing  
8/28/2015Keith R. DunleavyCEOBuy50,000$21.30$1,065,000.0050,000View SEC Filing  
8/27/2015Lee D. RobertsDirectorBuy24,000$21.05$505,200.0026,698View SEC Filing  
2/18/2015Shauna L VernalInsiderBuy10,000$27.00$270,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Inovalon (NASDAQ INOV) News Headlines

Source:
DateHeadline
Inovalon (INOV) Receives Consensus Recommendation of "Hold" from AnalystsInovalon (INOV) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 21 at 9:38 AM
Zacks: Brokerages Expect Inovalon (INOV) Will Announce Quarterly Sales of $146.28 MillionZacks: Brokerages Expect Inovalon (INOV) Will Announce Quarterly Sales of $146.28 Million
www.americanbankingnews.com - May 20 at 4:21 AM
Inovalon (INOV) Expected to Announce Earnings of $0.08 Per ShareInovalon (INOV) Expected to Announce Earnings of $0.08 Per Share
www.americanbankingnews.com - May 18 at 11:46 AM
Inovalon (INOV) CEO Buys $366,427.41 in StockInovalon (INOV) CEO Buys $366,427.41 in Stock
www.americanbankingnews.com - May 16 at 7:50 PM
Inovalon (INOV) CEO Purchases $1,169,380.00 in StockInovalon (INOV) CEO Purchases $1,169,380.00 in Stock
www.americanbankingnews.com - May 16 at 7:32 PM
Q2 2018 Earnings Forecast for Inovalon Issued By Piper Jaffray (INOV)Q2 2018 Earnings Forecast for Inovalon Issued By Piper Jaffray (INOV)
www.americanbankingnews.com - May 14 at 2:18 AM
Inovalon (INOV) Rating Lowered to Strong Sell at Zacks Investment ResearchInovalon (INOV) Rating Lowered to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - May 12 at 5:01 PM
Inovalon (INOV) Stock Rating Upgraded by BidaskClubInovalon (INOV) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - May 9 at 6:39 PM
Inovalon (INOV) Issues  Earnings Results, Misses Estimates By $0.10 EPSInovalon (INOV) Issues Earnings Results, Misses Estimates By $0.10 EPS
www.americanbankingnews.com - May 9 at 6:35 PM
Edited Transcript of INOV earnings conference call or presentation 8-May-18 9:00pm GMTEdited Transcript of INOV earnings conference call or presentation 8-May-18 9:00pm GMT
finance.yahoo.com - May 9 at 5:16 PM
BRIEF-Inovalon Reports Q1 Non-GAAP Loss Per Share $0.04BRIEF-Inovalon Reports Q1 Non-GAAP Loss Per Share $0.04
www.reuters.com - May 9 at 8:42 AM
Inovalons (INOV) CEO Keith Dunleavy on Q1 2018 Results - Earnings Call TranscriptInovalon's (INOV) CEO Keith Dunleavy on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 8:42 AM
Inovalon Holdings: 1Q Earnings SnapshotInovalon Holdings: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 8:42 AM
Inovalon (INOV) Releases FY18 Earnings GuidanceInovalon (INOV) Releases FY18 Earnings Guidance
www.americanbankingnews.com - May 8 at 6:16 PM
Inovalon misses by $0.10, misses on revenueInovalon misses by $0.10, misses on revenue
seekingalpha.com - May 8 at 5:18 PM
Inovalon Reports First Quarter 2018 ResultsInovalon Reports First Quarter 2018 Results
finance.yahoo.com - May 8 at 5:18 PM
Inovalon (INOV) Raised to "Hold" at ValuEngineInovalon (INOV) Raised to "Hold" at ValuEngine
www.americanbankingnews.com - May 3 at 10:34 PM
$106.88 Million in Sales Expected for Inovalon (INOV) This Quarter$106.88 Million in Sales Expected for Inovalon (INOV) This Quarter
www.americanbankingnews.com - May 2 at 2:00 AM
Research Report Identifies Cracker Barrel Old Country Store, Enova International, Natera, Inovalon,Research Report Identifies Cracker Barrel Old Country Store, Enova International, Natera, Inovalon,
www.nasdaq.com - May 1 at 8:44 AM
Research Report Identifies Cracker Barrel Old Country Store, Enova International, Natera, Inovalon, UMH Properties, and Progenics Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward MovementResearch Report Identifies Cracker Barrel Old Country Store, Enova International, Natera, Inovalon, UMH Properties, and Progenics Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
finance.yahoo.com - May 1 at 8:44 AM
$0.06 EPS Expected for Inovalon (INOV) This Quarter$0.06 EPS Expected for Inovalon (INOV) This Quarter
www.americanbankingnews.com - April 30 at 9:16 PM
Evertec (EVTC) vs. Inovalon (INOV) Head-To-Head ReviewEvertec (EVTC) vs. Inovalon (INOV) Head-To-Head Review
www.americanbankingnews.com - April 27 at 5:32 AM
Inovalon (INOV) Given Consensus Recommendation of "Hold" by AnalystsInovalon (INOV) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 26 at 10:10 AM
Zacks Investment Research Downgrades Inovalon (INOV) to HoldZacks Investment Research Downgrades Inovalon (INOV) to Hold
www.americanbankingnews.com - April 25 at 11:36 AM
Inovalon Announces First Quarter 2018 Earnings Conference CallInovalon Announces First Quarter 2018 Earnings Conference Call
feeds.benzinga.com - April 25 at 8:11 AM
Inovalon (INOV) Upgraded by BidaskClub to "Sell"Inovalon (INOV) Upgraded by BidaskClub to "Sell"
www.americanbankingnews.com - April 24 at 10:28 AM
Inovalon (INOV) to Release Earnings on TuesdayInovalon (INOV) to Release Earnings on Tuesday
www.americanbankingnews.com - April 24 at 6:35 AM
Form 8-K Inovalon Holdings, Inc. For: Apr 19Form 8-K Inovalon Holdings, Inc. For: Apr 19
www.streetinsider.com - April 21 at 8:35 AM
BidaskClub Lowers Inovalon (INOV) to BuyBidaskClub Lowers Inovalon (INOV) to Buy
www.americanbankingnews.com - April 19 at 9:04 AM
Inovalon (INOV) Upgraded by Zacks Investment Research to "Buy"Inovalon (INOV) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 17 at 11:03 AM
 Brokerages Anticipate Inovalon (INOV) Will Post Earnings of $0.06 Per Share Brokerages Anticipate Inovalon (INOV) Will Post Earnings of $0.06 Per Share
www.americanbankingnews.com - April 13 at 9:16 PM
Inovalon Completes Previously Announced Acquisition of ABILITY NetworkInovalon Completes Previously Announced Acquisition of ABILITY Network
finance.yahoo.com - April 10 at 8:52 AM
Inovalon Launches Clinical Data Extraction as a Service and Natural Language Processing as a Service on the Inovalon ONE™ PlatformInovalon Launches Clinical Data Extraction as a Service and Natural Language Processing as a Service on the Inovalon ONE™ Platform
finance.yahoo.com - April 10 at 8:52 AM
Inovalon (INOV) Lifted to "Equal Weight" at Morgan StanleyInovalon (INOV) Lifted to "Equal Weight" at Morgan Stanley
www.americanbankingnews.com - April 8 at 10:46 PM
William Blair Research Analysts Decrease Earnings Estimates for Inovalon (INOV)William Blair Research Analysts Decrease Earnings Estimates for Inovalon (INOV)
www.americanbankingnews.com - April 5 at 7:38 AM
Inovalon (INOV) Downgraded to Sell at Zacks Investment ResearchInovalon (INOV) Downgraded to Sell at Zacks Investment Research
www.americanbankingnews.com - April 1 at 7:00 PM
Inovalon Holdings Inc (INOV) Receives Average Recommendation of "Hold" from AnalystsInovalon Holdings Inc (INOV) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 1 at 9:36 AM
Inovalon (INOV) Upgraded at Zacks Investment ResearchInovalon (INOV) Upgraded at Zacks Investment Research
www.americanbankingnews.com - March 31 at 12:46 AM
Zacks Investment Research Downgrades Inovalon (INOV) to SellZacks Investment Research Downgrades Inovalon (INOV) to Sell
www.americanbankingnews.com - March 29 at 7:58 PM
$106.88 Million in Sales Expected for Inovalon Holdings Inc (INOV) This Quarter$106.88 Million in Sales Expected for Inovalon Holdings Inc (INOV) This Quarter
www.americanbankingnews.com - March 29 at 4:00 AM
Tech company Ability Network to expand Minneapolis officeTech company Ability Network to expand Minneapolis office
www.bizjournals.com - March 22 at 5:20 PM
Inovalon Holdings, Inc. -- Moodys assigns B2 CFR to Inovalon Holdings, Inc.; Outlook stableInovalon Holdings, Inc. -- Moody's assigns B2 CFR to Inovalon Holdings, Inc.; Outlook stable
finance.yahoo.com - March 20 at 5:02 PM
Analysis: Positioning to Benefit within AnaptysBio, MoSys, CONMED, Franklin Financial Network, Hersha Hospitality Trust, and Inovalon — Research Highlights Growth, Revenue, and Consolidated ResultsAnalysis: Positioning to Benefit within AnaptysBio, MoSys, CONMED, Franklin Financial Network, Hersha Hospitality Trust, and Inovalon — Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - March 20 at 8:50 AM
Inovalon (INOV) Stock Rating Lowered by ValuEngineInovalon (INOV) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - March 18 at 10:28 PM
Inovalon (INOV) Upgraded by TheStreet to "C"Inovalon (INOV) Upgraded by TheStreet to "C"
www.americanbankingnews.com - March 17 at 12:34 PM
Inovalon (INOV) Downgraded by Morgan Stanley to "Underweight"Inovalon (INOV) Downgraded by Morgan Stanley to "Underweight"
www.americanbankingnews.com - March 15 at 12:58 AM
Inovalon (INOV) Downgraded by ValuEngine to "Sell"Inovalon (INOV) Downgraded by ValuEngine to "Sell"
www.americanbankingnews.com - March 14 at 11:22 PM
Core Growth At Inovalon Slackening, Morgan Stanley Says In DowngradeCore Growth At Inovalon Slackening, Morgan Stanley Says In Downgrade
finance.yahoo.com - March 14 at 6:41 PM
Q3 2018 Earnings Estimate for Inovalon Holdings Inc Issued By KeyCorp (INOV)Q3 2018 Earnings Estimate for Inovalon Holdings Inc Issued By KeyCorp (INOV)
www.americanbankingnews.com - March 14 at 8:16 AM
Inovalon Holdings Inc (INOV) Expected to Announce Quarterly Sales of $106.88 MillionInovalon Holdings Inc (INOV) Expected to Announce Quarterly Sales of $106.88 Million
www.americanbankingnews.com - March 12 at 4:44 AM

SEC Filings

Inovalon (NASDAQ:INOV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Inovalon (NASDAQ:INOV) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Inovalon (NASDAQ INOV) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.